US Patent 9353394 Methods of producing hybrid antibodies
Patent 9353394 was granted and assigned to Regeneron Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9353394 Methods of producing hybrid antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
